Piperacillin, Tazobactam Drug Combination
An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS.
Year introduced: 2019 (1994)
PubMed search builder options
Subheadings:
Tree Number(s): D02.065.589.099.750.687.750.500, D02.065.589.099.750.750.050.650.500, D02.886.108.750.687.750.500, D02.886.108.750.750.050.650.500, D02.886.590.841.500, D03.633.100.300.750.687.750.500, D03.633.100.300.750.750.050.650.500, D26.310.625
MeSH Unique ID: D000077725
Registry Number: 157044-21-8
Entry Terms:
- Piperacillin - Tazobactam
- Piperacillin Tazobactam
- Tazobactam, Piperacillin -
- Piperacillin-Tazobactam Combination Product
- Piperacillin Tazobactam Combination Product
- Pipercillin Sodium, Tazobactam Sodium Drug Combination
- Pipercillin Sodium - Tazobactam Sodium
- Pipercillin Sodium Tazobactam Sodium
- Zosyn
- Tazocillin
- Tazocel
- Tazocin
Pharmacologic Action: